Pathology

Pediatric Pancreatic Cancer Diagnosed From cfDNA Fragments in Urine
Although rare, pancreatoblastoma is the most common pancreatic tumor of young children. Carcinoma of acinar cell origin has rarely been reported in older children. Ductal adenocarcinoma and its many variants are the most common pancreatic tumors in adults, but these are exceedingly rare in children. More...17 Mar 2021


Five Genes Help Predict Lewy Body Dementia
Lewy body dementia usually affects people over 65 years old. Early signs of the disease include hallucinations, mood swings, and problems with thinking, movements, and sleep. Patients who initially have cognitive and behavioral problems are usually diagnosed as having dementia with Lewy bodies, but are sometimes mistakenly diagnosed with Alzheimer’s disease. More...10 Mar 2021

Clinical Germline Testing Evaluated for Pediatric Cancer Patients
Pediatric cancer is rare, with fewer than 10,000 solid tumors diagnosed in children annually in the USA. Previous studies interrogating germline predisposition broadly across pediatric cancer types have found heritable germline predisposition in 8%–12% of patients. More...04 Mar 2021

Genetic Risk of Inflammatory Bowel Disease Appears Distinct in African Americans
The inflammatory bowel diseases Crohn’s disease (CD) and ulcerative colitis (UC) arise in the context of inappropriate activation of the intestinal immune system in response to an environmental trigger in individuals who are genetically predisposed. More...03 Mar 2021

ctDNA Provides Prognostic Clues in Advanced BRAF-Mutated Melanoma Cases
A BRAF mutation is a change in a BRAF gene. That change in the gene can lead to an alteration in a protein that regulates cell growth that could allow the melanoma to grow more aggressively. Approximately half of melanomas carry this mutation and are referred to as mutated, or BRAF positive. More...02 Mar 2021

22-Gene Genomic Classifier Validated in Recurrent Prostate Cancer Patients
When prostate cancer has been detected or has returned following initial treatment with surgery, radiation therapy and/or hormone therapy, it is said to be recurrent or relapsed. Treatment of recurrent prostate cancer depends on what treatment a patient has previously received and the extent of the cancer. More...25 Feb 2021
In Other News
Blood Biomarker Predicts Dementia in Cerebral Small Vessel Disease
Proteogenomic And Metabolomic Studies Characterize Human Glioblastoma
Exome Sequencing Identified Pathogenic Variants in Cerebral Palsy Patients
Biomarkers Evaluate Kidney Injury in Cancer Patients
Biomarker Predicts Pancreatic Cancer Patients’ Response to CD40 Immunotherapy
TAP1 Gene Polymorphisms Associated with Recurrent Respiratory Papillomatosis
Blood Test Detects Early Colorectal Adenomas
Liquid Biopsy Predicts Colon Cancer Relapse Months Earlier
Cell-Free DNA Detects Heart Allograft Acute Rejection
Proinflammatory T Cell Polarization Investigated in Early Knee Osteoarthritis
Alzheimer's Progression Tracked with Blood Biomarkers
Mismatch Repair/Microsatellite Instability Evaluated Using Cytology Effusion Specimens
Metastatic Gastric Cancer Outcomes Informed by Single-Cell Transcriptome Profiles
Alzheimer's Disease Subtypes Proposed from Brain Gene Expression Profiles
Common Brain Malformation Traced to Its Genetic Roots
Combination Urinary Biomarker Panel Detects Pancreatic Cancer Earlier
Multiplex Bead-Based Immunoassay Validated for Non-Invasive Bladder Cancer Detection
Single-Cell Transcriptome Links Gut Development, Pediatric Crohn's Disease
Rare Genetic Variants Can Contribute to Ischemic Heart Failure
Distinct Mutation Patterns Identified in Appendiceal Cancer
Circulating Tumor Cell Dynamics Predicts Cancer Prognosis
Flow Cytometry Employed in Diagnosing Male Urethritis
Gene Expression Signature Traces Nonalcoholic Fatty Liver Disease Progression
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.